ImmunoCellular Therapeutics Ltd (IMUC)

2.35
0.05 2.10
AMEX : Health Care
Prev Close 2.40
Open 2.40
Day Low/High 2.31 / 2.48
52 Wk Low/High 0.20 / 0.64
Volume 36.90K
Avg Volume 123.70K
Exchange AMEX
Shares Outstanding 3.46M
Market Cap 8.58M
EPS -7.90
Div & Yield N.A. (N.A)

Latest News

ImmunoCellular Therapeutics Provides Update On ICT-107 Phase 3 Glioblastoma Trial And Announces Advances In Stem-to-T-Cell Research Program

ImmunoCellular Therapeutics Provides Update On ICT-107 Phase 3 Glioblastoma Trial And Announces Advances In Stem-to-T-Cell Research Program

- ICT-107 Protocol Amendment Being Implemented in US Clinical Sites; Amended Protocol Submissions Underway in Europe and Canada.

What Adam Feuerstein Got Right and Wrong About Biotech Stocks in 2016

What Adam Feuerstein Got Right and Wrong About Biotech Stocks in 2016

TheStreet's biotech columnist offers his own report card on biotech stocks.

ImmunoCellular Therapeutics Reports Progress In Two Lead Cancer Immunotherapy Programs

ImmunoCellular Therapeutics Reports Progress In Two Lead Cancer Immunotherapy Programs

Over 100 Patients Screened in Phase 3 ICT-107 Trial in Newly Diagnosed Glioblastoma;

Blame for Northwest Bio Collapse Lies With CEO, Not With Mythical 'Wolfpack'

Blame for Northwest Bio Collapse Lies With CEO, Not With Mythical 'Wolfpack'

A defrocked analyst brushes off the serious problems weighing on Northwest Bio. Instead, he jacks the tired 'blame the shorts' excuse to another level.

ImmunoCellular Therapeutics Presents Updated ICT-107 Phase 2 Survival And Immune Response Data At The Society For Neuro-Oncology Annual Meeting 2015

ImmunoCellular Therapeutics Presents Updated ICT-107 Phase 2 Survival And Immune Response Data At The Society For Neuro-Oncology Annual Meeting 2015

Data support phase 3 registration trial incorporating key design modifications to potentially optimize outcomes

ImmunoCellular Therapeutics Appoints Mark A. Schlossberg And Gregg A. Lapointe To Its Board Of Directors

ImmunoCellular Therapeutics Appoints Mark A. Schlossberg And Gregg A. Lapointe To Its Board Of Directors

Mr. Schlossberg and Mr. Lapointe Will Serve as Independent Members of the Board of Directors